Korean J Fam Pract 2019; 9(4): 336-340  https://doi.org/10.21215/kjfp.2019.9.4.336
Usefulness of the Patient Health Questionnaire-2 in Screening for Depression
Minkyeung Jo1, Hye Yeon Koo2, In Young Cho2, Yoojin Lee1, Sojung Yoon1, Yeseul Yang1, Ju Young Kim2, Kiheon Lee2, Kee Hyuck Lee2, Se Young Jung2, Hyejin Lee2, Jong Soo Han3, Sarah Kim4, Woo Kyung Bae3,*
1Department of Family Medicine, Seoul National University Hospital, Seoul; 2Department of Family Medicine, Seoul National University Bundang Hospital; 3Department of Family Medicine, Health Promotion Center, Seoul National University Bundang Hospital; 4International Healthcare Center, Seoul National University Bundang Hospital, Seongnam, Korea
Woo Kyung Bae
Tel: +82-31-787-7805, Fax: +82-31-787-4078
E-mail: 65597@snubh.org
ORCID: http://orcid.org/0000-0001-6729-4128
Received: July 25, 2018; Revised: February 23, 2019; Accepted: June 3, 2019; Published online: August 20, 2019.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Background: While various screening tools are available for depression, they are not feasible in clinical practice because of their excessive number of questions. The Patient Health Questionnaire-2 (PHQ-2) consists of two questions gauging the frequency of depressed mood and anhedonia over the past two weeks. This study aimed to assess the usefulness of the PHQ-2 as a brief screening tool for depression.
Methods: This study used Korean National Health and Nutrition Examination Survey data from 2014, and the study population consisted of 4,946 individuals. We analyzed the validity of the PHQ-2 compared with ‘depression by PHQ-9,’ and obtained the optimal cut point for screening depression. The agreement between PHQ-2 and depression by PHQ-9 and the agreement between PHQ-2 and ‘currently diagnosed as depression’ were analyzed using Cohen’s kappa. The correlation between EuroQol-5D (EQ-5D) index scores and PHQ-2 scores was analyzed using Student’s t-test.
Results: Using ‘depression by PHQ-9’ as the criterion standard, PHQ-2 scores ≥2 had a sensitivity of 89% and a specificity of 87%, and a receiver operating characteristic analysis identified PHQ-2 ≥2 as the optimal cut point for screening. The agreement between PHQ-2 and depression by PHQ-9 was 0.430 when PHQ-2 ≥2 was used as a cut point. The agreement between PHQ-2 and ‘depression by questionnaire’ was poor. The EQ-5D index score of the depressive group was significantly lower than that of the normal group.
Conclusion: The PHQ-2 is an effective measure for screening depression and is expected to be useful in busy clinical settings.
Keywords: Depression; Mass Screening; Patient Health Questionnaire; Surveys and Questionnaires
References
  1. Ministry of Health and Welfare. The survey of mental disorders in Korea [Internet]. Sejong: Ministry of Health and Welfare; 2017 [cited 2018 Jun 29].
  2. World Health Organization. The global burden of disease: 2004 update [Internet]. Geneva: WHO; 2008. [cited 2018 Jun 29].
  3. Carter JD, Frampton CM, Mulder RT, Luty SE, Joyce PR. The relationship of demographic, clinical, cognitive and personality variables to the discrepancy between self and clinician rated depression. J Affect Disord 2010; 124: 202-6.
    Pubmed CrossRef
  4. Martin A, Rief W, Klaiberg A, Braehler E. Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry 2006; 28: 71-7.
    Pubmed CrossRef
  5. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003; 41: 1284-92.
    Pubmed CrossRef
  6. Saylor CF, Finch AJ Jr, Spirito A, Bennett B. The children's depression inventory:a systematic evaluation of psychometric properties. J Consult Clin Psychol 1984; 52: 955-67.
    Pubmed CrossRef
  7. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
    CrossRef
  8. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997; 35: 785-91.
    Pubmed CrossRef
  9. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983; 17: 37-49.
    Pubmed CrossRef
  10. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12: 439-45.
    Pubmed KoreaMed CrossRef
  11. Lim KH, Park YN, Kim DH, Shin IH, Lee WS, Kim JB. A preliminary study of the standardization of the Korean version of the Patient Health Questionnaire-9. Korean J Health Promot Dis Prev 2009; 9: 275-81.
  12. Nease DE Jr, Maloin JM. Depression screening: a practical strategy. J Fam Pract 2003; 52: 118-24.
    Pubmed
  13. An JY, Seo ER, Lim KH, Shin JH, Kim JB. Standardization of the Korean version of Screening Tool for Depression(Patient Health Questionnaire-9, PHQ-9). J Korean Soc Biol Ther Psychiatr 2013; 19: 47-56.
  14. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-13.
    Pubmed KoreaMed CrossRef
  15. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33: 337-43.
    Pubmed CrossRef
  16. Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health 2009; 12: 1187-93.
    Pubmed CrossRef
  17. Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010; 8: 348-53.
    Pubmed KoreaMed CrossRef
  18. Seo JG, Park SP. Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine. J Headache Pain 2015; 16: 65.
    Pubmed KoreaMed CrossRef
  19. Chagas MH, Crippa JA, Loureiro SR, Hallak JE, Meneses-Gaya Cd, Machado-de-Sousa JP, et al. Validity of the PHQ-2 for the screening of major depression in Parkinson's disease: two questions and one important answer. Aging Ment Health 2011; 15: 838-43.
    Pubmed CrossRef
  20. Richardson LP, Rockhill C, Russo JE, Grossman DC, Richards J, McCarty C, et al. Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics 2010; 125: e1097-103.
    Pubmed KoreaMed CrossRef
  21. Monahan PO, Shacham E, Reece M, Kroenke K, Ong'or WO, Omollo O, et al. Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya. J Gen Intern Med 2009; 24: 189-97.
    Pubmed KoreaMed CrossRef
  22. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005; 37: 360-3.
    Pubmed
  23. Shin JH, Kim HC, Jung CH, Kim JB, Jung SW, Cho HJ, et al. The standardization of the Korean version of the Patient Health Questionnaire-2. J Korean Neuropsychiatr Assoc 2013; 52: 115-21.
    CrossRef
  24. Myung SK, Jeong B, Lee WJ, Koh HJ, Suh SY, Yoo T, et al. Standardization of the two-question case-finding instrument as a screening instrument for the adolescent's depression. J Korean Acad Fam Med 2000; 21: 100-6.
  25. Sung SH, Lee HY, Shim SH, Jeong HY, Choi JS, Lee HS, et al. Survey of depression in the elderly patients with chronic obstructive pulmonary disease. J Korean Neuropsychiatr Assoc 2013; 52: 163-72.
    CrossRef


This Article

e-submission

Archives